pubmed-article:20113320 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0040405 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C1522619 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0851346 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0599880 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0021713 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C0205163 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C1517526 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C2349206 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
pubmed-article:20113320 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:20113320 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:20113320 | pubmed:dateCreated | 2010-8-23 | lld:pubmed |
pubmed-article:20113320 | pubmed:abstractText | Target volume definition in modern radiotherapy is based on planning computed tomography (CT). So far, 18-fluorodeoxyglucose positron emission tomography (FDG-PET) has not been included in planning modality in volume definition of esophageal cancer. This study evaluates fusion of FDG-PET and CT in patients with esophageal cancer in terms of geographic misses and inter-observer variability in volume definition. In 28 esophageal cancer patients, gross, clinical and planning tumor volumes (GTV; CTV; PTV) were defined on planning CT by three radiation oncologists. After software-based emission tomography and computed tomography (PET/CT) fusion, tumor delineations were redefined by the same radiation-oncologists. Concordance indexes (CCI's) for CT and PET/CT based GTV, CTV and PTV were calculated for each pair of observers. Incorporation of PET/CT modified tumor delineation in 17/28 subjects (61%) in cranial and/or caudal direction. Mean concordance indexes for CT-based CTV and PTV were 72 (55-86)% and 77 (61-88)%, respectively, vs. 72 (47-99)% and 76 (54-87)% for PET/CT-based CTV and PTV. Paired analyses showed no significant difference in CCI between CT and PET/CT. Combining FDG-PET and CT may improve target volume definition with less geographic misses, but without significant effects on inter-observer variability in esophageal cancer. | lld:pubmed |
pubmed-article:20113320 | pubmed:language | eng | lld:pubmed |
pubmed-article:20113320 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20113320 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20113320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20113320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20113320 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20113320 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20113320 | pubmed:issn | 1442-2050 | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:GroenHH | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:LangendijkJ... | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:van DamG MGM | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:JagerP LPL | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:PlukkerJ Th... | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:BeukemaJ CJC | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:SchreursL M... | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:BuszD MDM | lld:pubmed |
pubmed-article:20113320 | pubmed:author | pubmed-author:PaardekooperG... | lld:pubmed |
pubmed-article:20113320 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20113320 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:20113320 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20113320 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20113320 | pubmed:pagination | 493-501 | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:meshHeading | pubmed-meshheading:20113320... | lld:pubmed |
pubmed-article:20113320 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20113320 | pubmed:articleTitle | Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition. | lld:pubmed |
pubmed-article:20113320 | pubmed:affiliation | Department of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands. | lld:pubmed |
pubmed-article:20113320 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20113320 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |